International Journal of Health Policy and Management

International Journal of Health Policy and Management

Short-term Effects of Social Health Insurance Coverage of Assisted Reproductive Technologies on Pregnancies in Guangxi, China: An Interrupted Time Series Study

Document Type : Original Article

Authors
1 School of public health, Peking University, Beijing, China
2 China Center for Health Development Studies, Peking University, Beijing, China
3 Faculty of Health and Wellness, City University of Macau, Macau, China
4 Chinese Preventive Medicine Association, Beijing, China
5 National Health Commission Key Laboratory of Health System Reform and Governance, Peking University, Beijing, China
Abstract
Background
Assisted reproductive technologies (ARTs) provide effective treatment for infertility but are underutilized due to high costs. In November 2023, Guangxi province of China incorporated a range of ART procedures into social health insurance (SHI) coverage. This study aimed to evaluate the short-term impacts of the policy.

Methods
We used aggregated claims data from the Guangxi Healthcare Security Administration between January 2022 and July 2024, including 22 months before and 9 months after policy implementation. The primary study population comprised women with newly recorded pregnancies achieved through ARTs, identified through ICD-10 (International Classification of Diseases, 10th Revision) codes. We employed an interrupted time series (ITS) design to estimate the policy impact on monthly number of ART pregnancies and multiple pregnancy proportion among ART pregnancies. Non-ART pregnancies were additionally examined as a comparison series in a robustness analysis.

Results
After policy implementation, monthly ART pregnancies increased significantly, with an immediate level increase of 0.693 (P < .001) and a trend increase of 0.050 per month (P = .001) for the nine post-policy months. Multiple pregnancy proportion among ART pregnancies showed no significant level or trend change. Subgroup analyses indicated stronger and more sustained increases among women <40 years and enrollees in the Urban and Rural Resident Basic Medical Insurance (URRBMI). Geographically, areas with no or only one ART facility had larger immediate increases, while regions with two or more facilities showed a significant sustained upward trend.

Conclusion
In the first nine months after implementation, the inclusion of ART in Guangxi’s SHI program effectively increased pregnancies achieved through ARTs without raising multiple pregnancy proportion among ART pregnancies. These findings indicate that, in the short term, the policy improved access to ARTs and equity in access to reproductive healthcare among different population groups in a resource-constrained province in China.
Keywords

1.   World Health Organization. Infertility Prevalence Estimates, 1990-2021. https://www.who.int/publications/i/item/978920068315. Published 2022. Accessed February 18, 2025.
2.   Njagi P, Groot W, Arsenijevic J, Dyer S, Mburu G, Kiarie J. Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review. Hum Reprod Open. 2023;2023(2):hoad007. doi:10.1093/hropen/hoad007
3.   Peipert BJ, Montoya MN, Bedrick BS, Seifer DB, Jain T. Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment. Reprod Biol Endocrinol. 2022;20(1):111. doi:10.1186/s12958-022-00984-5
4.     Cha W, Yun I, Nam CM, Nam JY, Park EC. Evaluation of Assisted Reproductive Technology Health Insurance Coverage for Multiple Pregnancies and Births in Korea. JAMA Netw Open. 2023;6(6):e2316696. doi:10.1001/jamanetworkopen.2023.16696
5.     Lv H, Diao F, Du J, et al. Assisted reproductive technology and birth defects in a Chinese birth cohort study. Lancet Reg Health West Pac. 2021;7:100090. doi:10.1016/j.lanwpc.2020.100090
6.   Vélez MP, Connolly MP, Kadoch IJ, Phillips S, Bissonnette F. Universal coverage of IVF pays off. Hum Reprod. 2014;29(6):1313-1319. doi:10.1093/humrep/deu067
7.   Zagadailov P, Seifer DB, Shan H, Zarek SM, Hsu AL. Do state insurance mandates alter ICSI utilization? Reprod Biol Endocrinol. 2020;18(1):33. doi:10.1186/s12958-020-00589-w
8.   World Health Organization. Infertility. https://www.who.int/news-room/fact-sheets/detail/infertility. Published May 22, 2024. Accessed June 17, 2025.
9.   Zhang Y, Mills A, Xu J. Benefit equity of social health insurance in China and its provinces (2014-2020): implications for universal health coverage. BMJ Glob Health. 2024;9(11):e014806. doi:10.1136/bmjgh-2023-014806
10. China Daily. Guangxi medical insurance to cover test-tube baby services from November. China Daily website. https://govt.chinadaily.com.cn/s/202310/30/WS6543463d498ed2d7b7e9efb5/guangxi-medical-insurance-to-cover-test-tube-baby-services-from-november.html. Published October 30, 2023. Accessed July 31, 2025.
11. National Healthcare Security Administration. Assisted reproductive technologies included in medical insurance to ease financial burden. National Healthcare Security Administration website.  http://www.nhsa.gov.cn/art/2025/5/5/art_52_16450.html. Published May 5, 2025. Accessed July 31, 2025.
12. Zhou Z, Zheng D, Wu H, et al. Epidemiology of infertility in China: a population-based study. BJOG. 2018;125(4):432-441. doi:10.1111/1471-0528.14966
13. Huang R, Yu JY, He WC, Liu RH. Feasibility analysis of China's medical insurance coverage of assisted reproductive technology. Sci Rep. 2024;14(1):7998. doi:10.1038/s41598-024-58640-4
14. National Bureau of Statistics of China. Per Capita GDP. https://data.stats.gov.cn/english/easyquery.htm?cn=E0103. Published 2025. Accessed October 17, 2025.
15. National Bureau of Statistics of China. Population. https://data.stats.gov.cn/english/easyquery.htm?cn=E0103. Published 2025. Accessed October 17, 2025.
16. Guangxi Zhuang Autonomous Region Medical Security Bureau. Statistical Bulletin of Guangxi Medical Security Development in 2023. http://ybj.gxzf.gov.cn/zfxxgkzl/fdzdgknr/tjxx/t18936048.shtml. Published September 4, 2024. Accessed October 22, 2024.
17. Guangxi Zhuang Autonomous Region Medical Security Bureau, Guangxi Zhuang Autonomous Region Department of Human Resources and Social Security, Guangxi Zhuang Autonomous Region Health Commission. Notice on including selected therapeutic assisted reproductive medical services in the payment scope of basic medical insurance and work-related injury insurance funds. http://ybj.gxzf.gov.cn/xxgk/zcfg/zcfg_9912/xzgfxwj/t17370950.shtml. Published 2023. Accessed October 17, 2024.
18. Lopez Bernal J, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348-355. doi:10.1093/ije/dyw098
19. Linden A. Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata J. 2015;15(2):480-500. doi:10.1177/1536867x1501500208
20. Huang W, Wang Y, Wu H, et al. The motherhood penalty and low fertility in China: a pseudo-event study. J Popul Econ. 2025;38(28). doi:10.1007/s00148-025-01078-3
21. Tang Y, Fu R, Noguchi H. Impact of medical insurance integration on reducing urban-rural health disparity: Evidence from China. Soc Sci Med. 2024;357:117163. doi:10.1016/j.socscimed.2024.117163
22. Dieke AC, Mehta A, Kissin DM, Nangia AK, Warner L, Boulet SL. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015. Fertil Steril. 2018;109(4):691-697. doi:10.1016/j.fertnstert.2017.12.027
23. Yun I, Cha W, Nam CM, Nam JY, Park EC. The impact of assisted reproductive technology treatment coverage on marriage, pregnancy, and childbirth in women of childbearing age: an interrupted time-series analysis. BMC Public Health. 2023;23(1):1379. doi:10.1186/s12889-023-16286-3
24. Morshed-Behbahani B, Lamyian M, Joulaei H, et al. Infertility policy analysis: a comparative study of selected lower middle-middle- and high-income countries. Global Health. 2020;16(1):104.
25. Mackay A, Taylor S, Glass B. Inequity of access: scoping the barriers to assisted reproductive technologies. Pharmacy (Basel). 2023;11(1):17. doi:10.1186/s12992-020-00617-9
26. Boulet SL, Crawford S, Zhang Y, et al. Embryo transfer practices and perinatal outcomes by insurance mandate status. Fertil Steril. 2015;104(2):403-9.e1. doi:10.1016/j.fertnstert.2015.05.015
27. Kappy M, Plagianos M, Gingold J, Jindal S, Klugman S, Lieman H. Impact of in vitro fertilization insurance coverage in mandated vs nonmandated states in the United States before 2017. Fertil Steril. 2023;120(4):911-913. doi:10.1016/j.fertnstert.2023.07.005
28. Katagiri Y, Jwa SC, Kuwahara A, et al. Assisted reproductive technology in Japan: A summary report for 2022 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2024;23(1):e12620. doi:10.1002/rmb2.12620
29. Nippon.com. Annual births in Japan fall below 800,000 for the first time. Nippon.com website. https://www.nippon.com/en/japan-data/. Published February 28, 2023. Accessed June 30, 2025. 

Articles in Press, Corrected Proof
Available Online from 02 November 2026

Supplementary File
(IJHPM does not take responsibility for any information provided in the supplementary files.)

  • Received Date 27 January 2026
  • Revised Date 31 August 2026
  • Accepted Date 01 November 2026
  • First Published Date 02 November 2026
  • Published Date 02 November 2026